MAPT and Alzheimer disease: AD brains have increased tau phosphorylation that could be reversed by OGA inhibition, where OGA inhibition increases tau O-GlcNAcylation and prevents phosphorylation at the pathological tau phosphorylation sites (Yuzwa et al., 2008, 2012; Zhu et al., 2014).